Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RECQL5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SLC9A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CTLA4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100130872 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
GSX1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC01134 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VPS45 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CMTM3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CPT1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC01350 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
XIST - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AKR1C1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101930476 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GDAP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IQCA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL36A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEMG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GHSR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on